InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Showcases Single-Dose Mpox Vaccine Data at World Vaccine Congress
Tonix Pharmaceuticals (NASDAQ: TNXP), a fully-integrated biopharmaceutical company, presented positive preclinical data on its single-dose mpox vaccine candidate, TNX-801, at the World Vaccine Congress Washington 2025. The oral presentation highlighted TNX-801's efficacy in protecting animals—including immunocompromised subjects—against both mpox and rabbitpox, with durable protection lasting six months. The minimally replicative live-virus vaccine aligns with the World Health Organization’s preferred target profile, offering potential for broad…